Join to view full profile
200 East State Street, suite 100Media, PA 19063
Phone+1 610-891-9277
Dr. Littman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Susan Littman is an internal medicine specialist based in Media, PA, with subspecialties in geriatric medicine and hematology/oncology. She completed her fellowship in hematology and medical oncology at Duke University Hospital and her residency in internal medicine at the University of Texas Southwestern Medical Center. Dr. Littman is currently practicing at Rose Tree Medical. Her areas of expertise include internal medicine, gastrointestinal oncology, geriatrics and dementia, and hereditary predisposition to cancer. She has published extensively on topics like cancer treatment and gene mutations, with several articles cited by other publications multiple times. Dr. Littman has been involved in several clinical trials assessing treatments for pancreatic and liver cancer. She received recognition from various professional organizations, including awards for her contributions to hematology and oncology.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1993 - 1996
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1990 - 1993
Albany Medical CollegeClass of 1989
Certifications & Licensure
PA State Medical License 2006 - 2026
NC State Medical License 1993 - 2012
TX State Medical License 1992 - 1998
Awards, Honors, & Recognition
- VIP member, Woman of the Year National Association of Professional Women, 2014-2015
- Member National Association of Professional Women, 2014-2015
- Top Hematology-Oncology Specialist in PA International Association of Healthcare Professionals, 2014
Clinical Trials
- TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma
- A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer Start of enrollment: 2011 May 25
- Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients
Publications & Presentations
PubMed
- 26 citationsRecent Treatment Advances and Novel Therapies in Pancreas Cancer: A ReviewMatias E. Valsecchi, Enrique Díaz-Cantón, Máximo de la Vega, Susan J. Littman
Journal of Gastrointestinal Cancer. 2014-06-01 - 12 citationsReversible Posterior Leukoencephalopathy Syndrome Associated with Concurrent Bevacizumab, Gemcitabine, and Oxaliplatin for CholangiocarcinomaYongen Chang, Gilbert Mbeo, Susan J. Littman
Journal of Gastrointestinal Cancer. 2012-09-01 - 25 citationsIs there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinomaMatias E. Valsecchi, Thomas Holdbrook, Benjamin E. Leiby, Edward Pequignot, Susan J. Littman
BMC Cancer. 2012-03-22
Press Mentions
Susan J. Littman, M.D., Is Recognized by Continental Who's Who as a Trusted Internist in the Field of Medicine in Recognition of Her Role as Hematologist and Oncologist at Crozer Medical CenterOctober 14th, 2021- Dr. Susan Littman Receives IAOTP’s Lifetime Achievement AwardJune 21st, 2021
Esteemed Oncologist, Susan J. Littman, M.D., Continues to Earn High Praise for Her Unparalleled Work in Medicine, Prepares for Upcoming InterviewMarch 4th, 2019
Grant Support
- DNA Repair In Normal And Hypermutable Cancer Cell LinesNational Cancer Institute1996–2000
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
